J&J, Momenta lead drug stocks lower
January 25, 2011 at 11:41 AM EST
Shares of Johnson & Johnson run aground following a weaker-than-expected sales report.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.